Clinical Trials
Search our team at AdventHealth Research Institute
-
NCT04321031
STARZL NETWORK FOR EXCELLENCE IN PEDIATRIC TRANSPLANTATION (snept) to improve the health of pediatric LIVER TRANSPLANT PATIENTS
This study is currently enrolling.Associated Conditions: PediatricResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoPediatric liver transplantation has become the standard of care for many children with liver diseases. However, different institutions often treat and manage children with liver transplant in...
-
North American Pediatric Renal Trials Collaborative Studies (NAPRTCS)
This study is currently enrolling.Associated Conditions: PediatricResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoNAPRTCS is a research effort that was organized in 1987 by a group of physicians and surgeons committed to the success of pediatric renal transplant.
-
NCT03067181
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
This study is currently enrolling.Associated Conditions: Pediatric OncologyResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoLow Risk Subjects (Age <50 Years): The overall goal is to see if monitoring subjects with low risk germ cell tumors after their tumor is removed is as effective as following surgery with chemotherapy...
-
NCT03962543
A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients with Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) that are Progressing or Causing Significant Morbidity
This study is currently enrolling.Associated Conditions: PediatricResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoThis research is conducted to study an investigational drug referred to as PD-0325901 (also known as mirdametinib) that has not been approved by the US Food and Drug Administration (FDA) or any other...
-
NCT06739122
A Phase 3, Open-Label, Multicenter, Single-Arm Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Dulaglutide 3.0 mg and 4.5 mg in Pediatric Participants 10 to Less than 18 Years of Age with Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
This study is currently enrolling.Associated Conditions: PediatricResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoThis study will help us learn more about a study drug called dulaglutide. We are testing this study drug to find out if it helps kids and teens who have T2DM. We also want to find out if this study...
-
Discovery and Characterization of Genetic Risk Loci in Sjögren’s Syndrome
This study is currently enrolling.Associated Conditions: PediatricResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoThe purpose of this study of SD is to determine its cause, to improve understanding of it, and to help find new therapies. One very important part of this study is to compare the gene expression...
-
Childhood Sjogren Disease Long Term Outcomes
This study is currently enrolling.Associated Conditions: PediatricResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoThe purpose of this research is to describe the natural history of children diagnosed with, or suspected of being at risk for development of, childhood Sjogren Disease. This is a critically...
-
NCT03334292
Natural History of Wilson Disease: Registry for Patients with Wilson Disease
This study is currently enrolling.Associated Conditions: PediatricResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoYou are invited to donate your blood, urine, research data, and related information to be stored (banked) in a research specimen/data database or bank where it can be used for future research projects...
-
NCT05675410
A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
This study is currently enrolling.Associated Conditions: Pediatric OncologyResearch Area: Pediatric Research and Clinical TrialsResearch Location: Orlando -
NCT06639958
Risk-Based 6MP Adherence Enhancement Strategies in Children, Adolescent and Young Adults With ALL - A Pilot Study Study Sponsor: Children’s Oncology Group
This study is currently enrolling.Associated Conditions: Pediatric OncologyResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoThis study is being done to answer the following question: Can we help children, adolescents and young adults with ALL to remember to take their daily Maintenance medicine, 6MP, at home? We are doing...
-
NCT06172296
A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
This study is currently enrolling.Associated Conditions: Pediatric OncologyResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoThe overall goals of this study are to
Compare the outcomes of dinutuximab given early with Induction therapy to the effects of standard Induction therapy with the addition of dinutuximab later in... -
NCT05761171
AALL2121: A Phase 2 Study of SNDX-5613 in Combination with Chemotherapy for Patients with Relapsed or Refractory KMT2A-Rearranged Infant Leukemia
This study is currently enrolling.Associated Conditions: Pediatric OncologyResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoThe overall goal of this study is to determine the safety and best dose of the drug SNDX-5613 for young children when given in combination with chemotherapy, and to see if this treatment will improve...